These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 19383541)
1. In vitro and in vivo reproduction toxicology of 12 monoaminergic reuptake inhibitors: possible mechanisms of infrequent cardiovascular anomalies. Sloot WN; Bowden HC; Yih TD Reprod Toxicol; 2009 Sep; 28(2):270-82. PubMed ID: 19383541 [TBL] [Abstract][Full Text] [Related]
2. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing. Webster WS; Brown-Woodman PD; Ritchie HE Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342 [TBL] [Abstract][Full Text] [Related]
4. Developmental toxicity of mixtures: the water disinfection by-products dichloro-, dibromo- and bromochloro acetic acid in rat embryo culture. Andrews JE; Nichols HP; Schmid JE; Mole LM; Hunter ES; Klinefelter GR Reprod Toxicol; 2004 Nov; 19(1):111-6. PubMed ID: 15336719 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits. Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480 [TBL] [Abstract][Full Text] [Related]
6. Embryotoxicant-specific transcriptomic responses in rat postimplantation whole-embryo culture. Robinson JF; van Beelen VA; Verhoef A; Renkens MF; Luijten M; van Herwijnen MH; Westerman A; Pennings JL; Piersma AH Toxicol Sci; 2010 Dec; 118(2):675-85. PubMed ID: 20864626 [TBL] [Abstract][Full Text] [Related]
7. Different embryo-fetal toxicity effects for three VLA-4 antagonists. Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199 [TBL] [Abstract][Full Text] [Related]
8. Whole embryo culture and the identification of "teratogenicity". Scialli AR; Iannucci AR Reprod Toxicol; 2010 Apr; 29(2):247-8; author reply 249-50. PubMed ID: 19883752 [No Abstract] [Full Text] [Related]
9. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists. Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200 [TBL] [Abstract][Full Text] [Related]
11. Development of a streamlined rat whole embryo culture assay for classifying teratogenic potential of pharmaceutical compounds. Zhang C; Cao J; Kenyon JR; Panzica-Kelly JM; Gong L; Augustine-Rauch K Toxicol Sci; 2012 Jun; 127(2):535-46. PubMed ID: 22430072 [TBL] [Abstract][Full Text] [Related]
12. Embryotoxic potential of N-methyl-pyrrolidone (NMP) and three of its metabolites using the rat whole embryo culture system. Flick B; Talsness CE; Jäckh R; Buesen R; Klug S Toxicol Appl Pharmacol; 2009 Jun; 237(2):154-67. PubMed ID: 19281833 [TBL] [Abstract][Full Text] [Related]
13. The role of maternal toxicity in lovastatin-induced developmental toxicity. Lankas GR; Cukierski MA; Wise LD Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732 [TBL] [Abstract][Full Text] [Related]
14. Post-implantation embryo culture: validation with selected compounds for teratogenicity testing. Cicurel L; Schmid BP Xenobiotica; 1988 Jun; 18(6):617-24. PubMed ID: 3420940 [TBL] [Abstract][Full Text] [Related]
15. Embryotoxic and teratogenic effects of the combination of bisphenol A and genistein on in vitro cultured postimplantation rat embryos. Xing L; Xu Y; Xiao Y; Shang L; Liu R; Wei X; Jiang J; Hao W Toxicol Sci; 2010 Jun; 115(2):577-88. PubMed ID: 20299547 [TBL] [Abstract][Full Text] [Related]
16. A comparison of gene expression responses in rat whole embryo culture and in vivo: time-dependent retinoic acid-induced teratogenic response. Robinson JF; Verhoef A; Pennings JL; Pronk TE; Piersma AH Toxicol Sci; 2012 Mar; 126(1):242-54. PubMed ID: 22262565 [TBL] [Abstract][Full Text] [Related]
17. Effect of co-administration of retinoids on rat embryo development in vitro. Ritchie HE; Brown-Woodman PD; Korabelnikoff A Birth Defects Res A Clin Mol Teratol; 2003 Jun; 67(6):444-51. PubMed ID: 12962289 [TBL] [Abstract][Full Text] [Related]
18. Quantitative extrapolation of in vitro whole embryo culture embryotoxicity data to developmental toxicity in vivo using the benchmark dose approach. Piersma AH; Janer G; Wolterink G; Bessems JG; Hakkert BC; Slob W Toxicol Sci; 2008 Jan; 101(1):91-100. PubMed ID: 17905734 [TBL] [Abstract][Full Text] [Related]
19. Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure. Cappon GD; Cook JC; Hurtt ME Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):47-56. PubMed ID: 12852483 [TBL] [Abstract][Full Text] [Related]
20. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Ornoy A Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]